Vitamin D and Telomeres: VITAL Trial 4-Year Findings

Educational content - not professional advice. The information in this article is provided for general educational purposes only and does not constitute medical, nutritional, fitness, or professional advice. It is not a substitute for advice from a qualified healthcare professional. Always consult your GP or relevant specialist before starting any new exercise programme, diet, or health-related activity. DT Fitness London accepts no liability for decisions made based on the content of this article. See our Health & Exercise Disclaimer and Nutrition Disclaimer.

A randomised trial published in the American Journal of Clinical Nutrition reported a daily 2,000 IU vitamin D3 supplement reduced telomere loss by roughly 140 base pairs across four years in adults aged 50 and over. Telomeres are the protective caps on chromosome ends. They shorten as cells divide and as people age. Once a telomere drops below a critical length, the cell stops dividing or dies.

The finding comes from the VITAL Telomere sub-study, a 1,054-participant arm of the wider VITAL trial of 25,871 US adults. Participants gave blood samples at baseline, year 2, and year 4. The vitamin D3 group finished the four years with longer telomeres on average than the placebo group. Marine omega-3 supplementation, given at 1 gram per day, produced no significant effect.

140 bp
Telomere base pairs preserved over 4 years. VITAL Telomere, AJCN 2025, adults 50+.
2,000 IU
Daily vitamin D3 dose used in the VITAL trial intervention arm.
1,054
Participants in the VITAL Telomere sub-study, blood samples at 3 timepoints.
18%
UK adults aged 19 to 64 living with vitamin D deficiency. NDNS 2019 to 2023.

What the VITAL Telomere trial measured

VITAL is a large multi-year randomised trial run from Brigham and Women's Hospital. The team enrolled 25,871 US adults (women 55 and older, men 50 and older) into a 2 by 2 factorial design. Each participant received vitamin D3 at 2,000 IU per day or matching placebo, plus omega-3 fish oil at 1 gram per day or matching placebo, across a five-year intervention. The Telomere sub-study, led by Zhu and colleagues, recruited 1,054 of these participants at the Harvard Clinical and Translational Science Center.

The sub-study used absolute human telomere length quantification by polymerase chain reaction to measure leukocyte telomere length at baseline, year 2, and year 4. Mixed-effects linear regression compared the change in length across groups. Zhu and colleagues reported 140 base pairs (0.14 kilobase) less telomere shortening in the vitamin D3 group versus placebo over four years, with a 95 percent confidence interval of 7 to 270 base pairs and a p value of 0.039. Omega-3 produced no significant effect at year 2 or year 4.

The Mass General Brigham press release described the 140 base pair difference as equivalent to about three years of normal telomere shortening, based on a typical adult loss rate. The paper itself reports the raw difference. The biological direction is consistent: telomere loss slowed in the vitamin D3 group.

Why telomere length matters

Each cell division clips a small section of telomere DNA. Once the cap drops below a critical threshold, the cell enters senescence. Short leukocyte telomere length tracks chronological age and predicts higher risk of cardiovascular disease, certain cancers, and earlier all-cause mortality across cohort studies. Aubert and Lansdorp linked telomere loss to oxidative stress, chronic inflammation, and cellular replicative limits in their 2008 Physiological Reviews paper.

Leukocyte telomere length is not a perfect aging clock. Researchers still debate its value as a global aging marker, and short telomeres do not cause every age-related disease. Even so, leukocyte length reflects the cumulative replicative history of immune cells, and slowing the rate of loss is a plausible mechanism for reducing age-related cellular dysfunction. VITAL Telomere is the first large randomised dataset linking a single supplement, at a defined dose, to a measurable slowdown in telomere loss.

Vitamin D in UK food and supplements

Most UK adults fall short on vitamin D in winter. The National Diet and Nutrition Survey 2019 to 2023 found 18 percent of adults aged 19 to 64 deficient, rising to 31 percent during January to March. Adults aged 65 and over showed a lower rate of 12 percent in the same survey. Deficiency here means a serum 25-hydroxyvitamin D below 25 nmol per litre. Sunlight on bare skin is the main source between April and September. From October to March, UV-B levels in the UK are too weak for the skin to produce useful amounts of vitamin D.

NHS guidance is to take a daily supplement of 10 micrograms, equal to 400 IU, throughout autumn and winter. People with darker skin, those who cover up outdoors, and people who spend little time outside should supplement year round. The NHS upper safe limit is 100 micrograms, or 4,000 IU, per day. The VITAL trial dose of 2,000 IU falls between the NHS baseline recommendation and the upper limit.

Vitamin D in common UK servings
Micrograms vitamin D per serving Wild salmon, 140g 14 mcg Mackerel, 140g 12 mcg Supplement, 10 mcg 10 mcg Tinned sardines, 100g 7 mcg Trout, 140g 7 mcg Fortified cereal, 30g 1.7 mcg Large egg, 1 yolk 1 mcg Cow milk, 200ml UK 0.1 mcg Source: NHS food fact sheet, UK NDNS 2019 to 2023, BHF guidance. Values approximate.

Oily fish carries the highest vitamin D content per UK serving. Two 140 gram portions of salmon or mackerel per week match the NHS oily fish recommendation and contribute a useful share of weekly vitamin D. Eggs, fortified cereals, and fortified plant milks add smaller amounts. UK cow milk is not fortified by law, so milk is a weak source compared with the US or Canada.

A simple UK protocol

STEP 1
Cover the NHS baseline
Take 10 micrograms of vitamin D3 every day from October to March. Buy any reputable brand. Cost is around 5 pence per day.
STEP 2
Eat oily fish twice a week
A 140 gram portion of salmon, mackerel, sardines, herring, or trout twice a week supplies vitamin D, omega-3, and selenium together.
STEP 3
Get a blood test if you are unsure
Ask your GP for a serum 25-hydroxyvitamin D test if you are tired, low, or rarely outdoors. A reading below 25 nmol per litre needs a higher prescribed dose.

For most UK adults, 10 micrograms per day is the NHS baseline and a useful starting point. The VITAL trial dose of 2,000 IU, equal to 50 micrograms, stays well below the NHS safety ceiling of 100 micrograms. People with confirmed deficiency, darker skin, or limited outdoor exposure often need a higher daily dose under GP supervision.

Common mistakes to avoid

Skipping the supplement and relying on diet alone is the most common mistake. Reaching 10 micrograms per day from food is hard without oily fish on most days. Taking large doses without testing is a second mistake. Above 100 micrograms per day the NHS flags potential harm, including raised blood calcium. A third mistake is treating vitamin D as a single fix for fatigue or mood. Vitamin D is one input among many for energy and recovery. The VITAL Telomere finding is one mechanistic result on one cellular biomarker, not a cure for aging.

Frequently asked questions

Is 10 micrograms enough for an adult in London?
For most healthy UK adults the NHS 10 micrograms per day baseline is enough during autumn and winter. People with darker skin, those who cover up outdoors, and those who spend most of the day indoors should take 10 micrograms all year round. A blood test guides higher doses.
Why did omega-3 not help in the VITAL Telomere arm?
In the VITAL Telomere sub-study, marine omega-3 at 1 gram per day produced no significant change in leukocyte telomere length at year 2 or year 4. The wider VITAL trial reported other cardiovascular benefits, so the absence of a telomere effect does not rule out other uses of fish oil.
Does the telomere change translate to a longer life?
The VITAL Telomere paper reports a cellular biomarker change, not a survival outcome. Leukocyte telomere length tracks risk in cohort studies, but a 140 base pair difference in a four-year window has not been directly tied to a measurable lifespan benefit. The trial supports the mechanism. Long-term mortality data are still pending.
Is vitamin D3 better than D2?
Most evidence supports vitamin D3, the form used in VITAL, as the more effective option for raising blood 25-hydroxyvitamin D levels. The NHS allows both forms. Vegan products often use D2 or lichen-derived D3.
Should personal trainers in London discuss vitamin D with clients?
Personal trainers and nutrition coaches are not GPs. They should still flag NHS guidance, encourage oily fish in the weekly diet, and refer clients for a blood test when symptoms point to deficiency. The VITAL Telomere result adds to the evidence supporting a low-cost daily vitamin D3 supplement in autumn and winter.

Bottom line

VITAL Telomere is the first large randomised study linking daily 2,000 IU vitamin D3 to slower telomere loss over four years in adults aged 50 and over. Omega-3 produced no telomere effect in the same sub-study. For UK readers, the practical translation is straightforward: pair an NHS-recommended 10 microgram daily supplement with two weekly portions of oily fish, and ask your GP for a blood test if you suspect deficiency.

WORK WITH ME
Personal training and nutrition consultation in London.
If you want a training and nutrition plan built around your blood work, sleep, and goals, book a free consultation at www.dushyantatomar.com.

Sources

  1. Zhu H, Manson JE, Cook NR, et al. Vitamin D3 and marine omega-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial. The American Journal of Clinical Nutrition, 2025 Jul. PubMed 40409468
  2. NHS. Vitamin D. nhs.uk vitamin D guidance
  3. NHS UK. National Diet and Nutrition Survey reference range for vitamin D deficiency in UK adults. nhs.uk vitamin D deficiency
  4. Aubert G, Lansdorp PM. Telomeres and aging. Physiological Reviews, 2008. PubMed 18391173
  5. Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiologic Reviews, 2013. PubMed 23302541
Back to blog